Published in Ann Rheum Dis on September 01, 1973
Circulating and pokeweed mitogen-induced immunoglobulin-secreting cells in systemic lupus erythematosus. Clin Exp Immunol (1979) 1.74
Measles virus and its associated diseases. Bacteriol Rev (1977) 1.55
B cell activity in systemic lupus erythematosus: depressed in vivo humoral immune response to a primary antigen (haemocyanin) and increased in vitro spontaneous immunoglobulin synthesis. Clin Exp Immunol (1983) 1.22
Measles virus-specific antibodies and immunoglobulin M antiglobulin in sera from multiple sclerosis and rheumatoid arthritis patients. Infect Immun (1979) 0.87
Infection in systemic lupus erythematosus: friend or foe? Int J Clin Rheumtol (2010) 0.85
Local synovial synthesis of oligoclonal measles virus antibodies and of smooth muscle antibodies in a case of atypical rheumatoid arthritis. Ann Rheum Dis (1977) 0.82
Fluctuations in anti-nRNP levels in patients with mixed connective tissue disease are related to disease activity as part of a polyclonal B cell response. Ann Rheum Dis (1986) 0.81
Relationship of phytohaemagglutinin-induced lymphocyte transformation to disease activity in systemic lupus erythematosus. Ann Rheum Dis (1976) 0.79
A quantitative light- and electron-microscopic study of type IV nuclear bodies in crescentic glomerulonephritis. Am J Pathol (1981) 0.76
Proceedings: Antibodies to RNA in the connective tissue diseases. Ann Rheum Dis (1974) 0.75
Immunochemical quantitation of antigens by single radial immunodiffusion. Immunochemistry (1965) 96.68
DIAGNOSTIC criteria for rheumatoid arthritis: 1958 revision by a committee of the American Rheumatism Association. Ann Rheum Dis (1959) 26.58
Antibodies to polynucleotides in human sera: antigenic specificity and relation to disease. J Exp Med (1971) 4.62
The effect of induced chronic viral infections on the immunologic diseases of New Zealand mice. J Exp Med (1970) 2.16
Myxovirus antibody increases in human connective tissue disease. Science (1970) 1.94
A morphologic study on the occurrence and distribution of structures resembling viral nucleocapsids in collagen diseases. Am J Med (1972) 1.74
Raised antibody titres to E.B. virus in systemic lupus erythematosus. Lancet (1971) 1.60
Antibodies to viral antigens in systemic lupus erythematosus. Arthritis Rheum (1971) 1.42
Viruses and the connective tissue diseases. Ann Intern Med (1971) 1.37
Virus antibody levels in systemic lupus erythematosus. Arthritis Rheum (1972) 1.31
Antibody levels to parainfluenza, herpes simplex, varicella-zoster, cytomegalo virus, and measles virus in patients with connective tissue diseases. Ann Rheum Dis (1972) 1.11
Endothelial inclusions in dermatomyositis. Ann Rheum Dis (1970) 1.10
Serological investigations for evidence of an infectious aetiology of rheumatoid arthritis. Ann Rheum Dis (1971) 1.03
Epstein-Barr virus (herpes-type virus) antibodies in connective tissue diseases. Arch Intern Med (1972) 1.01
Viral isolation studies of inclusion positive biopsy from human connective tissue diseases. Arthritis Rheum (1970) 1.00
Virus antibody levels in rheumatoid arthritis and systemic lupus erythematosus. Acta Med Scand (1972) 1.00
Relationship between anti-viral antibodies and rheumatoid factor in pregnant women. Ann Rheum Dis (1966) 0.90
Heightened circulating antibody responses in New Zealand mice. J Lab Clin Med (1971) 0.83
A study of rubella haemagglutination inhibition antibodies in rheumatoid arthritis. Clin Exp Immunol (1970) 0.82
The natural history of systemic lupus erythematosus by prospective analysis. Medicine (Baltimore) (1971) 4.65
Association between polyarteritis and Australia antigen. Lancet (1970) 4.32
Anti-DNA activity in systemic lupus erythematosus. A diagnostic and therapeutic guide. Ann Rheum Dis (1971) 3.76
Two different subunits associate to create isoform-specific platelet-derived growth factor receptors. J Biol Chem (1989) 3.33
Experimental chronic glomerulitis. J Exp Med (1968) 2.44
Localization of fluorescein-labeled antinucleoside antibodies in glomeruli of patients with active systemic lupus erythematosus nephritis. J Clin Invest (1970) 2.41
Clinical and microbial features of prosthetic joint infection. Am J Med (1984) 2.31
Studies of cryoproteins in systemic lupus erythematosus. J Clin Invest (1967) 2.09
Studies of twins with systemic lupus erythematosus. A review of the literature and presentation of 12 additional sets. Am J Med (1975) 2.00
Vasculitis with hepatitis B antigenemia: long-term observation in nine patients. Medicine (Baltimore) (1976) 1.98
Myxovirus antibody increases in human connective tissue disease. Science (1970) 1.94
Character of non-precipitating antibodies. Immunology (1970) 1.79
Immune-complex disease. N Engl J Med (1969) 1.73
Platelet-derived growth factor (PDGF) and PDGF receptor are induced in mesangial proliferative nephritis in the rat. Proc Natl Acad Sci U S A (1991) 1.64
Character of anti-DNA antibodies in systemic lupus erythematosus. Clin Exp Immunol (1971) 1.56
The release of DNA into serum and synovial fluid. Arthritis Rheum (1971) 1.56
Necrotizing vasculitis after acute serous otitis media. Ann Intern Med (1974) 1.52
Vasculitis in the antiphospholipid syndrome. A cause of ischemia responding to corticosteroids. Arthritis Rheum (1992) 1.47
Aortic insufficiency in systemic lupus erythematosus. Arthritis Rheum (1969) 1.46
Decreased C'-1q protein concentration and agglutinating activity in agammaglobulinaemia syndromes: an inborn error reflected in the complement system. Clin Exp Immunol (1968) 1.41
Vasculitis in association with Australia antigen. J Exp Med (1971) 1.40
Vasculitis syndromes: clinical and experimental models. Am J Med (1976) 1.39
Hepatitis C virus and mixed cryoglobulinemia. Clin Exp Rheumatol (1992) 1.39
Clinical studies of hemolytic complement and the 11S component. Am J Med (1967) 1.39
Binding of immunoglobulin G aggregates and immune complexes in human sera to Staphylococci containing protein A. J Clin Invest (1979) 1.34
Properties of soluble immune complexes. J Immunol (1970) 1.31
Defective Fc receptor-mediated function of the mononuclear phagocyte system in lupus nephritis. Ann Intern Med (1982) 1.31
Rheumatoid meningitis: a localized immune process. Ann Intern Med (1979) 1.30
Alteration of ethanol self-administration by naltrexone. Life Sci (1980) 1.23
Serum protein binding of thyroxine and diphenylhydantoin. J Clin Endocrinol Metab (1966) 1.20
Autoantibodies to intracellular proteins. Clinical and biologic significance. Am J Med (1986) 1.17
High-dose intravenous methylprednisolone pulse therapy in systemic lupus erythematosus. Am J Med (1981) 1.17
Variable response to oral angiotensin-converting-enzyme blockade in hypertensive scleroderma patients. Arthritis Rheum (1982) 1.14
Sub-second changes in accumbal dopamine during sexual behavior in male rats. Neuroreport (2001) 1.14
Experimental rubella virus infection in the rhesus monkey. J Immunol (1965) 1.13
Naturally occurring low molecular weight IgM in patients with rheumatoid arthritis, systemic lupus erythematosus and macroglobulinemia. I. Purification and immunologic studies. J Immunol (1975) 1.11
Viruses and autoimmunity. Am J Med (1973) 1.10
Bengamides revisited: new structures and antitumor studies. J Org Chem (2001) 1.10
The occurrence and frequency of type C virus-like particles in placentas from patients with systemic lupus erythematosus and from normal subjects. Am J Pathol (1976) 1.09
Immunologic measurements of myoglobin in human adult and fetal skeletal muscle. Am J Physiol (1966) 1.08
Bilateral necrotising scleritis with marginal corneal ulceration after cataract surgery in a patient with vasculitis. Br J Ophthalmol (1980) 1.08
A technique for immunoassay of human IgG. Proc Soc Exp Biol Med (1970) 1.07
Oligodendrocyte-specific expression and autoantigenicity of transaldolase in multiple sclerosis. J Exp Med (1994) 1.05
Restriction endonuclease digestion eliminates product contamination in reverse transcribed polymerase chain reaction. J Virol Methods (1993) 1.02
Immunologic studies of autoimmune disease in NZB-NZW F1 mice. I. Binding of fluorescein-labeled antinucleoside antibodies in lesions of lupus-like nephritis. J Exp Med (1969) 1.01
Technetium-99m dimercaptosuccinic acid scintigraphy studies of renal cortical scarring and renal length. J Nucl Med (1998) 0.99
Epidemiology of childhood IDDM in U.S. Virgin Islands from 1979 to 1988. Evidence of an epidemic in early 1980s and variation by degree of racial admixture. Diabetes Care (1991) 0.99
Tetrachlorodibenzodioxin: an accidental poisoning episode in horse arenas. Science (1975) 0.98
Terminal effects of ethanol on dopamine dynamics in rat nucleus accumbens: an in vitro voltammetric study. Synapse (2001) 0.98
An aggressive form of polyarticular arthritis in a man with CD154 mutation (X-linked hyper-IgM syndrome). Arthritis Rheum (1999) 0.97
Antibody reactivity to the HRES-1 endogenous retroviral element identifies a subset of patients with systemic lupus erythematosus and overlap syndromes. Correlation with antinuclear antibodies and HLA class II alleles. Arthritis Rheum (1995) 0.94
Identification of bacterial antigens in circulating immune complexes of infective endocarditis. J Clin Invest (1982) 0.94
Synthesis and antitumor activity of ester-modified analogues of bengamide B. J Med Chem (2001) 0.94
Effect of acute ethanol on striatal dopamine neurotransmission in ambulatory rats. J Pharmacol Exp Ther (2001) 0.94
Fast food arthritis--a clinico-pathologic study of post-Salmonella reactive arthritis. J Rheumatol (1995) 0.93
Virus antibody levels and delayed hypersensitivity in rheumatoid arthritis. Ann Rheum Dis (1976) 0.93
Patients with systemic lupus erythematosus at risk for Pneumocystis carinii pneumonia. J Rheumatol (1992) 0.93
The virus hypothesis in systemic lupus erythematosus. Ann Intern Med (1975) 0.92
Studies on the first component of complement (C1) and the inhibitor of C1 esterase in rheumatoid synovial fluids. Clin Exp Immunol (1972) 0.91
Human synovial fibroblast plasminogen activator. Modulation of enzyme activity by antiinflammatory steroids. Arthritis Rheum (1981) 0.91
High IgM antibody to human T-lymphotropic virus type I in systemic lupus erythematosus. J Clin Immunol (1986) 0.90
Pathways of complement activation in glomerulonephritis. Kidney Int (1972) 0.90
Characterization of sequential immune complexes in infective endocarditis by Western blot analysis. J Immunol (1984) 0.90
Immunologic observations on 9 sets of twins either concordant or discordant for SLE. Arthritis Rheum (1976) 0.89
Polymorphic genotypes of the HRES-1 human endogenous retrovirus locus correlate with systemic lupus erythematosus and autoreactivity. Immunogenetics (1999) 0.89
Cellular immune responses to cartilage components in rheumatoid arthritis and osteoarthritis: a review and report of a study. Clin Exp Rheumatol (1988) 0.88
Serologic evidence of toxoplasmosis among patients with polymyositis. Am J Med (1974) 0.88
Receptor kinetics differ for endothelin-1 and endothelin-2 binding to Swiss 3T3 fibroblasts. Biochem Biophys Res Commun (1990) 0.88
Induction of polymeric IgA rheumatoid factors in infective endocarditis. Am J Med (1983) 0.87
Infectious agents in the pathogenesis of rheumatoid arthritis. Semin Arthritis Rheum (1986) 0.87
MAP1D, a novel methionine aminopeptidase family member is overexpressed in colon cancer. Oncogene (2006) 0.87
Specific antisera to Clr. Quantitation of Clr in normal and pathological human sera. Clin Exp Immunol (1974) 0.87
The effect of eyeglasses on self-esteem. J Am Optom Assoc (1983) 0.87
Virologic studies in rheumatoid arthritis and other connective tissue diseases. J Exp Med (1971) 0.86
Experimental rubella virus infection in pregnant monkeys. Am J Dis Child (1965) 0.86
Type C oncornavirus isolation studies in systemic lupus erythematosus. I. Attempted detection by isopycnic sedimentation of 3H-uridine-labelled virions. Ann Rheum Dis (1975) 0.86
Differences among immune complexes: association of C1q in SLE immune complexes with renal disease. J Immunol (1987) 0.86
Studies of hyperimmunization. Ann N Y Acad Sci (1965) 0.85
Viruses and systemic lupus erythematosus. Lancet (1973) 0.84
Type C oncornavirus isolation studies in systemic lupus erythematosus. II. Attempted detection by viral RNA-dependent DNA polymerase assay. Ann Rheum Dis (1978) 0.84
Half-life of exogenous growth hormone following suppression of endogenous growth hormone secretion with somatostatin in type I (insulin-dependent) diabetes mellitus. Clin Endocrinol (Oxf) (1992) 0.83
The influence of serum immunoglobulin concentration on measles antibody level. 1. Proc Soc Exp Biol Med (1972) 0.83
Isolation and characterization of circulating immune complexes in patients with hepatitis B systemic vasculitis. Clin Immunol Immunopathol (1981) 0.83
Editorial: Systemic lupus erythematosus and type C RNA viruses. N Engl J Med (1976) 0.82
Studies on experimental amyloidosis. Br J Exp Pathol (1966) 0.82
Comparative analysis of antibody and cell-mediated autoimmunity to transaldolase and myelin basic protein in patients with multiple sclerosis. J Clin Invest (1997) 0.81
Effect of aspirin on exercise-induced angina. Clin Pharmacol Ther (1978) 0.81
Virologic studies in rheumatoid arthritis. Rheumatology (1975) 0.81
Occurrence of antibodies to Borrelia burgdorferi in patients with nonspirochetal subacute bacterial endocarditis. Ann Intern Med (1993) 0.81
The effect of steroids on the clearance and fate of bacteria. J Reticuloendothel Soc (1968) 0.81
Serial circulating immune complexes and mononuclear phagocyte system function in infective endocarditis. J Lab Clin Med (1983) 0.81
Hypoglycaemia after initiation of treatment with etanercept in a patient with type 2 diabetes mellitus. Ann Rheum Dis (2007) 0.81
Amino acids and collagen-induced platelet aggregation. Lack of effect of three amino acids that are elevated in homocystinuria. Am J Dis Child (1975) 0.81
How do bacteria cause chronic arthritis? J Rheumatol (1989) 0.81
Type C viruses and systemic lupus erythematosus. Arthritis Rheum (1978) 0.80
The interaction of soluble immune complexes with rheumatoid factors. Ann N Y Acad Sci (1969) 0.80